Impact of severe mitral regurgitation on patients with 'De Novo' heart failure and reduced ejection fraction: baseline characteristics and survival analysis

31 August 2025 (12:15 - 13:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Miguel Mejuto Blanco

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

3 More presentations in this session

Presentation thumbnail

Quantifying the impact of real-world evidence: the sacubitril/valsartan experience

Doctor S. Rathore (Kankakee, US)

Abstract Slides Video

Presentation thumbnail

In patients with heart failure with unplanned admission to hospital lack of improvement in quality-of-life 2 months after discharge identifies individuals at very high risk of readmission or death.

Mrs M. Mcginlay (Leeds, GB)

Abstract Slides Video

Presentation thumbnail

Heart rate control in heart failure: insights from nationwide multicenter registry HEROES.

Professor J. Kasprzak (Lodz, PL)

Abstract Slides Video

Access the full session

Session thumbnail

Epidemiology, prognosis, and outcome in chronic heart failure (3)

The Event

Event poster

ESC Congress 2025

31 August 2025 12:15 CET

You may be interested in

Congress Presentation

Impact of severe mitral regurgitation on patients with 'De Novo' heart failure and reduced ejection fraction: baseline characteristics and survival analysis

Congress Presentation

Prognostic significance of mitral regurgitation in acute heart failure stratified by ejection fraction

Congress Presentation

Clinical characteristics and prognostic significance of different heart failure types stratified by ejection fraction in patients with acute heart failure and severe tricuspid regurgitation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources